BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 37343344)

  • 21. Progressive brain microstructural damage in patients with multiple sclerosis but not in patients with neuromyelitis optica spectrum disorder: A cross-sectional and follow-up tract-based spatial statistics study.
    Chen X; Roberts N; Zheng Q; Peng Y; Han Y; Luo Q; Zeng C; Wang J; Luo T; Li Y
    Mult Scler Relat Disord; 2021 Oct; 55():103178. PubMed ID: 34384989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optical Coherence Tomography and Magnetic Resonance Imaging in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder.
    Manogaran P; Hanson JV; Olbert ED; Egger C; Wicki C; Gerth-Kahlert C; Landau K; Schippling S
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27854301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Personalized Estimates of Brain Structural Variability in Individuals With Early Psychosis.
    Antoniades M; Haas SS; Modabbernia A; Bykowsky O; Frangou S; Borgwardt S; Schmidt A
    Schizophr Bull; 2021 Jul; 47(4):1029-1038. PubMed ID: 33547470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Imaging Differences between Neuromyelitis Optica Spectrum Disorders and Multiple Sclerosis: A Multi-Institutional Study in Japan.
    Tatekawa H; Sakamoto S; Hori M; Kaichi Y; Kunimatsu A; Akazawa K; Miyasaka T; Oba H; Okubo T; Hasuo K; Yamada K; Taoka T; Doishita S; Shimono T; Miki Y
    AJNR Am J Neuroradiol; 2018 Jul; 39(7):1239-1247. PubMed ID: 29724765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spinal cord and brain atrophy patterns in neuromyelitis optica spectrum disorder and multiple sclerosis.
    Hua T; Fan H; Duan Y; Tian D; Chen Z; Xu X; Bai Y; Li Y; Zhang N; Sun J; Li H; Li Y; Li Y; Zeng C; Han X; Zhou F; Huang M; Xu S; Jin Y; Li H; Zhuo Z; Zhang X; Liu Y
    J Neurol; 2024 Jun; 271(6):3595-3609. PubMed ID: 38558149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of myelin water fraction values in periventricular white matter lesions between multiple sclerosis and neuromyelitis optica spectrum disorder.
    Jeong IH; Choi JY; Kim SH; Hyun JW; Joung A; Lee J; Kim HJ
    Mult Scler; 2016 Oct; 22(12):1616-1620. PubMed ID: 26920375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The usefulness of brain MRI at onset in the differentiation of multiple sclerosis and seropositive neuromyelitis optica spectrum disorders.
    Huh SY; Min JH; Kim W; Kim SH; Kim HJ; Kim BJ; Kim BJ; Lee KH
    Mult Scler; 2014 May; 20(6):695-704. PubMed ID: 24072726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Personalized estimates of brain cortical structural variability in individuals with Autism spectrum disorder: the predictor of brain age and neurobiology relevance.
    Xie Y; Sun J; Man W; Zhang Z; Zhang N
    Mol Autism; 2023 Jul; 14(1):27. PubMed ID: 37507798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Difference in fatigue and pain between neuromyelitis optica spectrum disorder and multiple sclerosis.
    Masuda H; Mori M; Uzawa A; Uchida T; Ohtani R; Kuwabara S
    PLoS One; 2020; 15(4):e0224419. PubMed ID: 32251416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative analysis of glymphatic system alterations in multiple sclerosis and neuromyelitis optica spectrum disorder using MRI indices from diffusion tensor imaging.
    Kim M; Hwang I; Park JH; Chung JW; Kim SM; Kim JH; Choi KS
    Hum Brain Mapp; 2024 Apr; 45(5):e26680. PubMed ID: 38590180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain and spinal MRI features distinguishing MS from different AQP4 antibody serostatus NMOSD at disease onset in a cohort of Latin American patients.
    Carnero Contentti E; Marques VD; Soto de Castillo I; Tkachuk V; Barreira AA; Caride A; Castillo MC; Cristiano E; de Aquino Cruz C; Braga Diégues Serva G; Santos ACD; Labarca R; Lavigne Moreira C; López PA; Miguez J; Molina O; Pettinicchi JP; Rojas JI
    Mult Scler; 2020 Jul; 26(8):945-954. PubMed ID: 31124748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multimodal magnetic resonance imaging quantification of gray matter alterations in relapsing-remitting multiple sclerosis and neuromyelitis optica spectrum disorder.
    Andica C; Hagiwara A; Yokoyama K; Kato S; Uchida W; Nishimura Y; Fujita S; Kamagata K; Hori M; Tomizawa Y; Hattori N; Aoki S
    J Neurosci Res; 2022 Jul; 100(7):1395-1412. PubMed ID: 35316545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differentiation between multiple sclerosis and neuromyelitis optica spectrum disorder using a deep learning model.
    Seok JM; Cho W; Chung YH; Ju H; Kim ST; Seong JK; Min JH
    Sci Rep; 2023 Jul; 13(1):11625. PubMed ID: 37468553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brain parenchymal damage in neuromyelitis optica spectrum disorder - A multimodal MRI study.
    Pache F; Zimmermann H; Finke C; Lacheta A; Papazoglou S; Kuchling J; Wuerfel J; Hamm B; Ruprecht K; Paul F; Brandt AU; Scheel M
    Eur Radiol; 2016 Dec; 26(12):4413-4422. PubMed ID: 27012555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroanatomical heterogeneity and homogeneity in individuals at clinical high risk for psychosis.
    Baldwin H; Radua J; Antoniades M; Haas SS; Frangou S; Agartz I; Allen P; Andreassen OA; Atkinson K; Bachman P; Baeza I; Bartholomeusz CF; Chee MWL; Colibazzi T; Cooper RE; Corcoran CM; Cropley VL; Ebdrup BH; Fortea A; Glenthøj LB; Hamilton HK; Haut KM; Hayes RA; He Y; Heekeren K; Kaess M; Kasai K; Katagiri N; Kim M; Kindler J; Klaunig MJ; Koike S; Koppel A; Kristensen TD; Bin Kwak Y; Kwon JS; Lawrie SM; Lebedeva I; Lee J; Lin A; Loewy RL; Mathalon DH; Michel C; Mizrahi R; Møller P; Nelson B; Nemoto T; Nordholm D; Omelchenko MA; Pantelis C; Raghava JM; Røssberg JI; Rössler W; Salisbury DF; Sasabayashi D; Schall U; Smigielski L; Sugranyes G; Suzuki M; Takahashi T; Tamnes CK; Tang J; Theodoridou A; Thomopoulos SI; Tomyshev AS; Uhlhaas PJ; Værnes TG; van Amelsvoort TAMJ; Van Erp TGM; Waltz JA; Westlye LT; Wood SJ; Zhou JH; McGuire P; Thompson PM; Jalbrzikowski M; Hernaus D; Fusar-Poli P;
    Transl Psychiatry; 2022 Jul; 12(1):297. PubMed ID: 35882855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dorsal medulla surface texture: Differentiating neuromyelitis optica spectrum disorder from multiple sclerosis.
    Okuda DT; Stanley T; McCreary M; Smith AD; Burgess KW; Wilson A; Guo X; Moog TM
    J Neuroimaging; 2022 Nov; 32(6):1090-1097. PubMed ID: 36181675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison between the cranial magnetic resonance imaging features of neuromyelitis optica spectrum disorder versus multiple sclerosis in Taiwanese patients.
    Liao MF; Chang KH; Lyu RK; Huang CC; Chang HS; Wu YR; Chen CM; Chu CC; Kuo HC; Ro LS
    BMC Neurol; 2014 Nov; 14():218. PubMed ID: 25433369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of MRI Lesion Evolution in Different Central Nervous System Demyelinating Disorders.
    Sechi E; Krecke KN; Messina SA; Buciuc M; Pittock SJ; Chen JJ; Weinshenker BG; Lopez-Chiriboga AS; Lucchinetti CF; Zalewski NL; Tillema JM; Kunchok A; Monaco S; Morris PP; Fryer JP; Nguyen A; Greenwood T; Syc-Mazurek SB; Keegan BM; Flanagan EP
    Neurology; 2021 Sep; 97(11):e1097-e1109. PubMed ID: 34261784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
    Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J
    Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Macular vessel density differs in multiple sclerosis and neuromyelitis optica spectrum disorder: An optical coherence tomography angiography study.
    Rogaczewska M; Michalak S; Stopa M
    PLoS One; 2021; 16(6):e0253417. PubMed ID: 34138942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.